{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T18:35:28Z","timestamp":1776191728684,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,18]]},"DOI":"10.7759\/cureus.54407","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T18:16:56Z","timestamp":1708280216000},"source":"Crossref","is-referenced-by-count":1,"title":["A Pathology Experience of Posttransplant Lymphoproliferative Disorder From One Tertiary Hospital: Pathology Concepts and Diagnostic Approach"],"prefix":"10.7759","author":[{"given":"Haneen","family":"Al-Maghrabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayan","family":"Hafiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelrazak","family":"Meliti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02899918","article-title":"Post-transplant lymphoproliferative disorders","volume":"3","author":"Lewin KJ","year":"1997","unstructured":"Lewin KJ. Post-transplant lymphoproliferative disorders. Pathol Oncol Res. 1997, 3:177-82. 10.1007\/BF02899918","journal-title":"Pathol Oncol Res"},{"key":"ref2","article-title":"Classification of the posttransplant lymphoproliferative disorders: From the past to the present","volume":"14","author":"Swerdlow SH","year":"1997","unstructured":"Swerdlow SH. Classification of the posttransplant lymphoproliferative disorders: From the past to the present. Semin Diag Pathol. 1997, 14:2-7.","journal-title":"Semin Diag Pathol"},{"key":"ref3","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. Vol. 2","author":"Swerdlow SH","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris N L, et al.. WHO classification of tumours of haematopoietic and lymphoid tissues. Vol. 2. 2008."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-010-0132-1","article-title":"Post-transplantation lymphoproliferative disorders: Diagnosis, prognosis, and current approaches to therapy","volume":"12","author":"Evens AM","year":"2010","unstructured":"Evens AM, Roy R, Sterrenberg D, Moll MZ, Chadburn A, Gordon LI. Post-transplantation lymphoproliferative disorders: Diagnosis, prognosis, and current approaches to therapy. Curr Oncol Rep. 2010, 12:383-94. 10.1007\/s11912-010-0132-1","journal-title":"Curr Oncol Rep"},{"key":"ref5","article-title":"Posttransplant lymphoproliferative disease after lung transplantation","volume":"2013","author":"Neuringer IP","year":"2013","unstructured":"Neuringer IP. Posttransplant lymphoproliferative disease after lung transplantation. J Immunol Res. 2013, 2013:1-12.","journal-title":"J Immunol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels EA","year":"2011","unstructured":"Engels EA, Pfeiffer RM, Fraumeni JF, et al.. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011, 306:1891-901. 10.1001\/jama.2011.1592","journal-title":"JAMA"},{"key":"ref7","article-title":"Post\u2010transplant lymphoproliferative disorders and other malignancies after pediatric intestinal transplantation: Incidence, clinical features and outcome","volume":"17","author":"Ramos E","year":"2013","unstructured":"Ramos E, Hern\u00e1ndez F, Andres A, et al.. Post\u2010transplant lymphoproliferative disorders and other malignancies after pediatric intestinal transplantation: Incidence, clinical features and outcome. Pedia transplant. 2013, 17:472-8.","journal-title":"Pedia transplant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21911","article-title":"Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States","volume":"86","author":"Quinlan SC","year":"2011","unstructured":"Quinlan SC, Pfeiffer RM, Morton LM, Engels EA. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol. 2011, 86:206-9. 10.1002\/ajh.21911","journal-title":"Am J Hematol"},{"key":"ref9","article-title":"Clinicopathologic features of post\u2010transplant lymphoproliferative disorders arising after pediatric small bowel transplant","volume":"17","author":"Nassif S","year":"2013","unstructured":"Nassif S, Kaufman S, Vahdat S, Yazigi N, Kallakury B, Island E, Ozdemirli M. Clinicopathologic features of post\u2010transplant lymphoproliferative disorders arising after pediatric small bowel transplant. Pedia transplant. 2013, 17:765-73.","journal-title":"Pedia transplant"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.2001.003002070","article-title":"Identifying the patient at risk for post\u2010transplant lymphoproliferative disorder","volume":"3","author":"Cockfield S","year":"2001","unstructured":"Cockfield S. Identifying the patient at risk for post\u2010transplant lymphoproliferative disorder. Transpl Infect Dis. 2001, 3:70-8. 10.1034\/j.1399-3062.2001.003002070","journal-title":"Transpl Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300314","article-title":"Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation","volume":"30","author":"HEzode C","year":"1999","unstructured":"HEzode C, Duvoux C, Germanidis G, et al.. Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation. Hepatology. 1999, 30:775-8. 10.1002\/hep.510300314","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2000.tb02070.x","article-title":"Lymphoproliferative disorders in heart transplant recipients: Role of hepatitis C virus (HCV) and Epstein\u2010Barr virus (EBV) infection","volume":"13","author":"Buda A","year":"2000","unstructured":"Buda A, Caforio A, Calabrese F, et al.. Lymphoproliferative disorders in heart transplant recipients: Role of hepatitis C virus (HCV) and Epstein\u2010Barr virus (EBV) infection. Transpl Internat. 2000, 13:402-5. 10.1111\/j.1432-2277.2000.tb02070.x","journal-title":"Transpl Internat"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000269617.60751.c4","article-title":"Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients","volume":"84","author":"Babel N","year":"2007","unstructured":"Babel N, Vergopoulos A, Trappe RU, et al.. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients. Transplantation. 2007, 84:387-91. 10.1097\/01.tp.0000269617.60751.c4","journal-title":"Transplantation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03454.x","article-title":"Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients","volume":"11","author":"Reshef R","year":"2011","unstructured":"Reshef R, Luskin MR, Kamoun M, et al.. Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients. Am J Transplant. 2011, 11:817-25. 10.1111\/j.1600-6143.2011.03454.x","journal-title":"Am J Transplant"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjc.6605278","article-title":"Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease","volume":"101","author":"McAulay K","year":"2009","unstructured":"McAulay K, Haque T, Crawford D. Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease. Br J cancer. 2009, 101:1019-27.","journal-title":"Br J cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.2001.003002060.x","article-title":"The Epstein-Barr virus and post-transplant lymphoproliferative disease: Interplay of immunosuppression, EBV, and the immune system in disease pathogenesis","volume":"3","author":"Tanner JE","year":"2001","unstructured":"Tanner JE, Alfieri C. The Epstein-Barr virus and post-transplant lymphoproliferative disease: Interplay of immunosuppression, EBV, and the immune system in disease pathogenesis. Transpl Infect Dis. 2001, 3:60-9. 10.1034\/j.1399-3062.2001.003002060.x","journal-title":"Transpl Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard S","year":"2005","unstructured":"Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation. 2005, 80:1233-43. 10.1097\/01.tp.0000179639.98338.39","journal-title":"Transplantation"},{"key":"ref18","article-title":"Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study","volume":"94","author":"Curtis RE","year":"1999","unstructured":"Curtis RE, Travis LB, Rowlings PA, et al.. Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study. Blood. 1999, 94:2208-16.","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-011791","article-title":"Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation","volume":"108","author":"Brunstein CG","year":"2006","unstructured":"Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA, Wagner JE. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood. 2006, 108:2874-80. 10.1182\/blood-2006-03-011791","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7182\/pit2013122","article-title":"Risk evaluation and mitigation strategies: A focus on belatacept","volume":"23","author":"Sam T","year":"2013","unstructured":"Sam T, Gabardi S, Tichy EM. Risk evaluation and mitigation strategies: A focus on belatacept. Prog Transplant. 2013, 23:64-70. 10.7182\/pit2013122","journal-title":"Prog Transplant"},{"key":"ref21","article-title":"Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders","volume":"147","author":"Oudejans JJ","year":"1995","unstructured":"Oudejans JJ, Jiwa M, van den Brule AJ, et al.. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. Am J Pathol. 1995, 147:923-33.","journal-title":"Am J Pathol"},{"key":"ref22","article-title":"Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation","volume":"58","author":"Rea D","year":"1994","unstructured":"Rea D, Fourcade C, Leblond V, et al.. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Transplantation. 1994, 58:317-24.","journal-title":"Transplantation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2014.68","article-title":"In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications","volume":"27","author":"Gonzalez-Farre B","year":"2014","unstructured":"Gonzalez-Farre B, Rovira J, Martinez D, et al.. In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications. Mod Pathol. 2014, 27:1599-611. 10.1038\/modpathol.2014.68","journal-title":"Mod Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.966242","article-title":"Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders","volume":"56","author":"Vase M\u00d8","year":"2015","unstructured":"Vase M\u00d8, Maksten EF, Bendix K, et al.. Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders. Leuk Lymphoma. 2015, 56:1677-85. 10.3109\/10428194.2014.966242","journal-title":"Leuk Lymphoma"},{"key":"ref25","article-title":"The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders","volume":"146","author":"Delecluse HJ","year":"1995","unstructured":"Delecluse HJ, Kremmer E, Rouault JP, Cour C, Bornkamm G, Berger F. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. Am J Pathol. 1995, 146:1113-20.","journal-title":"Am J Pathol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2000.tb02066.x","article-title":"Incidence and clinical characteristics of posttransplant lymphoproliferative disorders: Report from a single center","volume":"13","author":"Muti G","year":"2000","unstructured":"Muti G, De Gasperi A, Cantoni S, et al.. Incidence and clinical characteristics of posttransplant lymphoproliferative disorders: Report from a single center. Transpl Int. 2000, 13: S382-7. 10.1111\/j.1432-2277.2000.tb02066.x","journal-title":"Transpl Int"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(96)90369-X","article-title":"Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients","volume":"27","author":"Wu T-t","year":"1996","unstructured":"Wu T-t, Swerdlow SH, Locker J, et al.. Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. Hum Pathol. 1996, 27:157-64. 10.1016\/S0046-8177(96)90369-X","journal-title":"Hum Pathol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01106.x","article-title":"Proteomics analysis in post-transplant lymphoproliferative disorders","volume":"81","author":"Alsayed Y","year":"2008","unstructured":"Alsayed Y, Leleu X, Leontovich A, Oton AB, Melhem M, George D, Ghobrial IM. Proteomics analysis in post-transplant lymphoproliferative disorders. Eur J Haematol. 2008, 81:298-303. 10.1111\/j.1600-0609.2008.01106.x","journal-title":"Eur J Haematol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02781.x","article-title":"Activation of the JAK\/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: Role of interferon-gamma","volume":"9","author":"Vaysberg M","year":"2009","unstructured":"Vaysberg M, Lambert SL, Krams SM, Martinez OM. Activation of the JAK\/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: Role of interferon-gamma. Am J Transplant. 2009, 9:2292-302. 10.1111\/j.1600-6143.2009.02781.x","journal-title":"Am J Transplant"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-438549","article-title":"Early onset, EBV(-) PTLD in pediatric liver-small bowel transplantation recipients: A spectrum of plasma cell neoplasms with favorable prognosis","volume":"121","author":"Perry AM","year":"2013","unstructured":"Perry AM, Aoun P, Coulter DW, Sanger WG, Grant WJ, Coccia PF. Early onset, EBV(-) PTLD in pediatric liver-small bowel transplantation recipients: A spectrum of plasma cell neoplasms with favorable prognosis. Blood. 2013, 121:1377-83. 10.1182\/blood-2012-06-438549","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1086\/517427","article-title":"Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line","volume":"177","author":"Srinivas SK","year":"1998","unstructured":"Srinivas SK, Sample JT, Sixbey JW. Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line. J Infect Dis. 1998, 177:1705-9. 10.1086\/517427","journal-title":"J Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02740.x","article-title":"Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma","volume":"113","author":"Kapelushnik J","year":"2001","unstructured":"Kapelushnik J, Ariad S, Benharroch D, Landau D, Moser A, Delsol G, Brousset P. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. Br J Haematol. 2001, 113:425-8. 10.1046\/j.1365-2141.2001.02740.x","journal-title":"Br J Haematol"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1038\/sj.leu.2401390","article-title":"Primary effusion lymphoma after heart transplantation: A new entity associated with human herpesvirus-8","volume":"13","author":"Dotti G","year":"1999","unstructured":"Dotti G, Fiocchi R, Motta T, et al.. Primary effusion lymphoma after heart transplantation: A new entity associated with human herpesvirus-8. Leukemia. 1999, 13:664-70.","journal-title":"Leukemia"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12196","article-title":"Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders","volume":"13","author":"Morscio J","year":"2013","unstructured":"Morscio J, Dierickx D, Ferreiro JF, et al.. Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders. Am J Transplant. 2013, 13:1305-16. 10.1111\/ajt.12196","journal-title":"Am J Transplant"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.780655","article-title":"Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: Incidence, clinicopathological characteristics and prognostic factors","volume":"54","author":"Dierickx D","year":"2013","unstructured":"Dierickx D, Tousseyn T, Sagaert X, et al.. Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: Incidence, clinicopathological characteristics and prognostic factors. Leuk Lymphoma. 2013, 54:2433-40. 10.3109\/10428194.2013.780655","journal-title":"Leuk Lymphoma"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.1097\/00000478-200003000-00006","article-title":"Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: A distinct entity?","volume":"24","author":"Nelson BP","year":"2000","unstructured":"Nelson BP, Nalesnik MA, Bahler DW, Locker J, Fung J, Swerdlow S. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: A distinct entity?. Am J Surg Pathol. 2000, 24:375-85.","journal-title":"Am J Surg Pathol"},{"key":"ref37","article-title":"Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression","volume":"10","author":"Armitage J","year":"1991","unstructured":"Armitage J, Kormos RL, Stuart RS, et al.. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression. J Heart lung transplant. 1991, 10:877-86.","journal-title":"J Heart lung transplant"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/hon.859","article-title":"Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology","volume":"26","author":"Vakiani E","year":"2008","unstructured":"Vakiani E, Basso K, Klein U, et al.. Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. Hematol Oncol. 2008, 26:199-211. 10.1002\/hon.859","journal-title":"Hematol Oncol"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.12211","article-title":"Primary CNS posttransplant lymphoproliferative disease (PTLD): An international report of 84 cases in the modern era","volume":"13","author":"Evens AM","year":"2013","unstructured":"Evens AM, Choquet S, Kroll-Desrosiers AR, et al.. Primary CNS posttransplant lymphoproliferative disease (PTLD): An international report of 84 cases in the modern era. Am J Transplant. 2013, 13:1512-22.","journal-title":"Am J Transplant"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPQYYE04AVGVYI","article-title":"Early posttransplant lymphoproliferative disease: Clinicopathologic features and correlation with mTOR signaling pathway activation","volume":"138","author":"Nelson BP","year":"2012","unstructured":"Nelson BP, Wolniak KL, Evens A, Chenn A, Maddalozzo J, Proytcheva M. Early posttransplant lymphoproliferative disease: Clinicopathologic features and correlation with mTOR signaling pathway activation. Am J Clin Pathol. 2012, 138:568-78. 10.1309\/AJCPQYYE04AVGVYI","journal-title":"Am J Clin Pathol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12091","article-title":"Plasmacytic post-transplant lymphoproliferative disorder: A case series of nine patients","volume":"26","author":"Karuturi M","year":"2013","unstructured":"Karuturi M, Shah N, Frank D, et al.. Plasmacytic post-transplant lymphoproliferative disorder: A case series of nine patients. Transpl Int. 2013, 26:616-22. 10.1111\/tri.12091","journal-title":"Transpl Int"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02183.x","article-title":"EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: Results of a two-arm prospective trial","volume":"8","author":"Tsai DE","year":"2008","unstructured":"Tsai DE, Douglas L, Andreadis C, et al.. EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: Results of a two-arm prospective trial. Am J Transplant. 2008, 8:1016-24. 10.1111\/j.1600-6143.2008.02183.x","journal-title":"Am J Transplant"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2007.05.009","article-title":"Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection","volume":"26","author":"Ahya VN","year":"2007","unstructured":"Ahya VN, Douglas LP, Andreadis C, et al.. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection. J Heart Lung Transplant. 2007, 26:839-44. 10.1016\/j.healun.2007.05.009","journal-title":"J Heart Lung Transplant"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/150835","article-title":"Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: What do we know so far?","volume":"2013","author":"Morscio J","year":"2013","unstructured":"Morscio J, Dierickx D, Tousseyn T. Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: What do we know so far?. Clin Dev Immunolo. 2013, 2013:150835. 10.1155\/2013\/150835","journal-title":"Clin Dev Immunolo"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2009.11.016","article-title":"Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: Incidence and prognostic factors","volume":"41","author":"Montanari F","year":"2010","unstructured":"Montanari F, O'Connor OA, Savage DG, et al.. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: Incidence and prognostic factors. Hum Pathol. 2010, 41:1150-8. 10.1016\/j.humpath.2009.11.016","journal-title":"Hum Pathol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08161.x","article-title":"Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines","volume":"149","author":"Parker A","year":"2010","unstructured":"Parker A, Bowles K, Bradley JA, et al.. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines. Br J Haematol. 2010, 149:675-92. 10.1111\/j.1365-2141.2010.08161.x","journal-title":"Br J Haematol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000282","article-title":"EBV-positive mucocutaneous ulcer in organ transplant recipients: A localized indolent posttransplant lymphoproliferative disorder","volume":"38","author":"Hart M","year":"2014","unstructured":"Hart M, Thakral B, Yohe S, Balfour HH Jr, Singh C, Spears M, McKenna RW. EBV-positive mucocutaneous ulcer in organ transplant recipients: A localized indolent posttransplant lymphoproliferative disorder. Am J Surg Pathol. 2014, 38:1522-9. 10.1097\/PAS.0000000000000282","journal-title":"Am J Surg Pathol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer\u2014A study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov SD","year":"2010","unstructured":"Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer\u2014A study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010, 34:405-17. 10.1097\/PAS.0b013e3181cf8622","journal-title":"Am J Surg Pathol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-6053(97)80005-1","article-title":"Post-transplant lymphoproliferative disorders: A working classification","volume":"4","author":"Swerdlow S","year":"1997","unstructured":"Swerdlow S. Post-transplant lymphoproliferative disorders: A working classification. Curr Diag Pathol. 1997, 4:28-35. 10.1016\/S0968-6053(97)80005-1","journal-title":"Curr Diag Pathol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.162","article-title":"Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1","volume":"30","author":"Montes-Moreno S","year":"2017","unstructured":"Montes-Moreno S, Martinez-Magunacelaya N, Zecchini-Barrese T, et al.. Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1. Mod Pathol. 2017, 30:85-94. 10.1038\/modpathol.2016.162","journal-title":"Mod Pathol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0b013e3181c2c0b5","article-title":"Primary cutaneous giant cell plasmacytoma in an organ transplant recipient: A rare presentation of a posttransplant lymphoproliferative disorder","volume":"32","author":"Wang E","year":"2010","unstructured":"Wang E, Stoecker M. Primary cutaneous giant cell plasmacytoma in an organ transplant recipient: A rare presentation of a posttransplant lymphoproliferative disorder. Am J Dermatopathol. 2010, 32:479-85. 10.1097\/DAD.0b013e3181c2c0b5","journal-title":"Am J Dermatopathol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182190999","article-title":"EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: A distinct type of posttransplant lymphoproliferative disorder?","volume":"35","author":"Gibson SE","year":"2011","unstructured":"Gibson SE, Swerdlow SH, Craig FE, et al.. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: A distinct type of posttransplant lymphoproliferative disorder?. Am J Surg Pathol. 2011, 35:807-15. 10.1097\/PAS.0b013e3182190999","journal-title":"Am J Surg Pathol"},{"key":"ref53","article-title":"Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients","volume":"24","author":"Hsi ED","year":"2000","unstructured":"Hsi ED, Singleton TP, Swinnen L,  Dunphy CH, Alkan S. Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients. Am J Surg Pathol. 2000, 24:100.","journal-title":"Am J Surg Pathol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.775436","article-title":"Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: Single-center series of nine cases and meta-analysis of 147 reported cases","volume":"54","author":"Herreman A","year":"2013","unstructured":"Herreman A, Dierickx D, Morscio J, et al.. Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: Single-center series of nine cases and meta-analysis of 147 reported cases. Leuk Lymphoma. 2013, 54:2190-9. 10.3109\/10428194.2013.775436","journal-title":"Leuk Lymphoma"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.2.587.587","article-title":"Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation","volume":"83","author":"Gorochov G","year":"1994","unstructured":"Gorochov G, Debre P, Leblond V, Sadat-Sowti B, Sigaux F, Autran B. Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. Blood. 1994, 83:587-95. 10.1182\/blood.V83.2.587.587","journal-title":"Blood"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1046\/j.1397-3142.2003.00113.x","article-title":"Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient","volume":"8","author":"Dharnidharka VR","year":"2004","unstructured":"Dharnidharka VR, Douglas VK, Hunger SP, Fennell RS. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient. Pediatr Transplant. 2004, 8:87-90. 10.1046\/j.1397-3142.2003.00113.x","journal-title":"Pediatr Transplant"},{"key":"ref57","article-title":"Molecular genetic analysis of lymphoid tumors arising after organ transplantation","volume":"135","author":"Locker J","year":"1989","unstructured":"Locker J, Nalesnik M. Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol. 1989, 135:977-87.","journal-title":"Am J Pathol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(98)90127-7","article-title":"Clonal and morphological variation in a posttransplant lymphoproliferative disorder: Evolution from clonal T-cell to clonal B-cell predominance","volume":"29","author":"Nelson BP","year":"1998","unstructured":"Nelson BP, Locker J, Nalesnik MA, Fung JJ, Swerdlow SH. Clonal and morphological variation in a posttransplant lymphoproliferative disorder: Evolution from clonal T-cell to clonal B-cell predominance. Hum pathol. 1998, 29:416-21. 10.1016\/S0046-8177(98)90127-7","journal-title":"Hum pathol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.186","article-title":"Presence of monoclonal T-cell populations in B-cell post-transplant lymphoproliferative disorders","volume":"24","author":"Ibrahim HA","year":"2011","unstructured":"Ibrahim HA, Menasce LP, Pomplun S, Burke M, Bower M, Naresh KN. Presence of monoclonal T-cell populations in B-cell post-transplant lymphoproliferative disorders. Mod Pathol. 2011, 24:232-40. 10.1038\/modpathol.2010.186","journal-title":"Mod Pathol"},{"key":"ref60","article-title":"Epstein-Barr virus-negative lymphoproliferative disorders in long-term survivors after heart, kidney, and liver transplant","volume":"69","author":"Dotti G","year":"2000","unstructured":"Dotti G, Fiocchi R, Motta T, et al.. Epstein-Barr virus-negative lymphoproliferative disorders in long-term survivors after heart, kidney, and liver transplant. Transplantation. 2000, 69:827-33.","journal-title":"Transplantation"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65029-8","article-title":"Expression of p16\/INK4a in posttransplantation lymphoproliferative disorders","volume":"156","author":"Martin A","year":"2000","unstructured":"Martin A, Baran-Marzak F, El Mansouri S, et al.. Expression of p16\/INK4a in posttransplantation lymphoproliferative disorders. Am J Pathol. 2000, 156:1573-9. 10.1016\/S0002-9440(10)65029-8","journal-title":"Am J Pathol"},{"key":"ref62","doi-asserted-by":"crossref","DOI":"10.1038\/labinvest.3780419","article-title":"Gene mutations in lymphoproliferative disorders of T and NK\/T cell phenotypes developing in renal transplant patients","volume":"82","author":"Hoshida Y","year":"2002","unstructured":"Hoshida Y, Hongyo T, Nakatsuka SI, et al.. Gene mutations in lymphoproliferative disorders of T and NK\/T cell phenotypes developing in renal transplant patients. Lab Investig. 2002, 82:257-64.","journal-title":"Lab Investig"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/224807-a-pathology-experience-of-posttransplant-lymphoproliferative-disorder-from-one-tertiary-hospital-pathology-concepts-and-diagnostic-approach","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T18:17:06Z","timestamp":1708280226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/224807-a-pathology-experience-of-posttransplant-lymphoproliferative-disorder-from-one-tertiary-hospital-pathology-concepts-and-diagnostic-approach"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,18]]},"references-count":62,"URL":"https:\/\/doi.org\/10.7759\/cureus.54407","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,18]]}}}